St. Anthony's fire (ergotamine induced leg ischemia): A case report and review of the literature

Angiology

Volumn 52, Issue 5, 2001, Pages 349-356

  Zavaleta, Ernesto G ^a   Fernandez, Bernardo B ^a   Grove, Mark K ^a   Kaye, Marc D ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOTAMINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PRAZOSIN; VASODILATOR AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG EFFECT; DRUG USE; ERGOTISM; FEMALE; HUMAN; LEG ANGIOGRAPHY; LEG ISCHEMIA; MIGRAINE; VASODILATATION;

EID: 0034999636     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970105200509     Document Type: Article

References (38)

1. Ancalmo N, Ochsner J: Peripheral ischemia secondary to ergotamine intoxication. Arch Surg 109:832-834, 1974.
2. Paraskevopoulos J, Teasdale D, Cuschieri R: Severe reversible arterial spasm with ergotamine. Br J Clin Pract 49:214, 1995.
3. Goodman RL, Gilman JB (eds): The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill, 1995, pp 491-493.
4. Hemingway D: Ergot poisoning with multisystem involvement. Milit Med 10:257-260, 1965.
5. Silberstein S: The Pharmacology of ergotamine and dihydroergotamine. Headache 37(suppl 1):S15-S25, 1997.
6. Merhoff G, Porter J: Ergot intoxication: Historical review and description of unusual clinical manifestations. Ann Surg 180:773, 1974.
7. Meyler W: Side effects of ergotamine: Review. Cephalalgia 16:5-10, 1996.
8. Muller-Schweinitzer E, Rosenthaler J: Dihydro-ergotamine: Pharmacokinetics, pharmacodynamics and mechanism of venoconstrictor action in beagle dogs. J Cardiovasc Pharmacol 9:686-693, 1987.
9. Ibraheem J, Paalzow L, Tfelt-Hansen P: Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. Eur J Clin Pharmacol 23:235-240, 1982.
10. Tfelt-Hansen P: The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol (Copenh) 59(suppl 3):1-30, 1986.
11. Muller-Schweinitzer E: In vitro studies on the duration of action of dihydroergotamine. Int J Clin Pharmacol 18:88-91, 1980.
12. Faberger S, Jorulf H, Sanderg C: Ergotism, arteriospastic disease and recovery, studied angiographically. Acta Med Scand 182:769-772, 1967.
13. Fukui S, Coggia M, Goeau-Brissonniere O: Acute upper extremity ischemia during concomitant use of ergotamine tartrate and ampicillin. Ann Vasc Surg 11:420-424, 1997.
14. Hayton A: Precipitation of acute ergotism by triacetyloendomycin. NZ Med J 69:42-50, 1969.
15. Venter C, Joubert P, Buys A: Severe peripheral ischemia during concomitant use of beta-blockers and ergot alkaloids. Br Med J 289:288-289, 1984.
16. Enge I, Sivertssen E: Ergotism due to therapeutic doses of ergotamine tartrate. Am Heart J 70:665-670, 1965.
17. Cairols M, Gimenez A, Sieyro F, et al: Intoxicacion ergotaminica. Dos casos de ischemia periferica. Angiologia (Spain) 4:148-152, 1991.
18. Bagby R, Cooper R: Angiography in ergotism. Report of two cases and review of the literature. Am J Roentgenol Radium Ther Nucl Med 116:179-186, 1972.
19. Pader E: Leriche syndrome in a patient with prolonged and continuous use of ergot derivatives. Vasc Dis 4:380-388, 1967.
20. Weaver R, Phillips M, Vacek J: St. Anthony's Fire: A medieval disease in modern times: Case history. Angiology 40:929-932, 1989.
21. Mathey D, Montz R, Hanrath P, et al: Non-invasive method for recognition of coronary artery spasm: 201 thallium sequential scintigraphy of the myocardium after ergotamine provocation. Dtsch Wochenschr 105:509-515, 1980.
22. Goldfisher J: Acute myocardial infarction secondary to ergot therapy. New Engl J Med 262:860, 1960.
23. Fedotin M, Hartman C: Ergotamine poisoning producing renal arterial spasm. New Engl J Med 283:518-520, 1970.
24. Greene F, Ariyan S, Stansel H: Mesenteric and peripheral vascular ischemia secondary to ergotism. Surgery 81:176-179, 1977.
25. Ritcher A, Banker V: Carotid ergotism. A complication of migraine therapy. Radiology 106:339-340, 1973.
26. Lazarides M, Karageorgiou C, Tsiara S, et al: Severe facial ischemia caused by ergotism. J Cardiovasc Surg 33:383-385, 1992.
27. Tarnower A, Alguire P: Ergotism masquerading as arteritis. Postgrad Med J 85:103-108, 1989.
28. Tfelt-Hansen P, Olesen J. Arterial response to ergotamine tartrate in abusing and nonabusing migraine patients. Acta Pharmacol Toxicol 48:69-72, 1981.
29. Curry R, Yalamanchili R: Recurrent ergotism: A case report. J Fam Pract 6:769-773, 1978.
30. Bongard O, Bounameaux H: Severe iatrogenic ergotism: Incidence and clinical importance. VASA 20:153-156, 1991.
31. Diege-Petersen H, Lassen N, Tonnensen K, et al: Subclinical ergotism. Lancet 2:65-66, 1977.
32. Tfelt-Hansen P, Eickhoff J, Olesen J: The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: Methodological aspects and time effect curve. Acta Pharmacol Toxicol 47:151-156, 1980.
33. Wells K, Steed D, Zajko A, et al: Recognition and treatment of arterial insufficiency from cafergot. J Vasc Surg 4:8-15, 1986.
34. Hussun B, Metz P, Rasmusen J: Nitroglycerin infusion for ergotism. Lancet 2:794-795, 1979.
35. Kermerer V, Daghen F, Pais S: Successful treatment of ergotism with nifedipine. Am J Roentgenol 143:333-334, 1984.
36. Piquemal R, Emmerich J, Guilmot J, et al: Successful treatment of ergotism with iloprost: A case report. Angiology 49:493-497, 1998.
37. Shifrin E, Olschwang D, Perel A, et al: Reversal of ergotamine-induced arteriospasm by mechanical intraarterial dilatation. Lancet 13:1278-1279, 1980.
38. Lepantalo M, Rosenberg P, Pohjola J, et al: Epidural spinal cord stimulation in the treatment of limb threatening vasospasm - report of a case with a five-year follow-up. Eur J Vasc Endovasc Surg 11:368-370, 1996.